SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-15-004580
Filing Date
2015-08-14
Accepted
2015-08-14 16:10:46
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 287762
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4968
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3093
  Complete submission text file 0001062993-15-004580.txt   4311965

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE avxl-20150630.xml EX-101.INS 397775
5 XBRL SCHEMA FILE avxl-20150630.xsd EX-101.SCH 159629
6 XBRL CALCULATION FILE avxl-20150630_cal.xml EX-101.CAL 30000
7 XBRL DEFINITION FILE avxl-20150630_def.xml EX-101.DEF 451242
8 XBRL LABEL FILE avxl-20150630_lab.xml EX-101.LAB 1028063
9 XBRL PRESENTATION FILE avxl-20150630_pre.xml EX-101.PRE 496054
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-51652 | Film No.: 151055862
SIC: 8731 Services-Commercial Physical & Biological Research